✨ Medicines Classification




2070

NEW ZEALAND GAZETTE, No. 91

22 JUNE 2009

Oseltamivir; except when sold by a registered pharmacist between the months of May to September inclusive for the treatment of seasonal influenza to a consumer 12 years of age or more presenting in a pharmacy with early symptoms of influenza; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic

Sulfamethoxazole; except when combined with trimethoprim in a medicine that is supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic

Trimethoprim; except when combined with sulfamethoxazole in a medicine that is supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic

Zanamivir; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic

Dated this 19th day of June 2009.

STEPHEN McKERNAN, Director-General of Health.

go5328


PUBLISHED BY THE
DEPARTMENT OF INTERNAL AFFAIRS
PRINTED BY SECURACOPY

ISSN 0111-5650
ISSN 1177-8415
Price $1.60 (inc. GST)




Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 91





✨ LLM interpretation of page content

πŸ₯ Classification of Prescription Medicines under the Medicines Act 1981 (continued from previous page)

πŸ₯ Health & Social Welfare
19 June 2009
Medicines, Prescription, Classification, Oseltamivir, Sulfamethoxazole, Trimethoprim, Zanamivir, Influenza, Pandemic
  • STEPHEN McKERNAN, Director-General of Health